Literature DB >> 17005472

Radiofrequency ablation for hepatocellular carcinoma and liver metastases: experience in Hospital La Paz.

Silvia Gómez Senent1, César Gómez Raposo, Noemi Manceñido Marcos, Sonia Martín Chavarri, Gemma Carrión Alonso, Antonio Olveira Martín, José María Segura Cabral, Manuel González Barón.   

Abstract

INTRODUCTION: Radiofrequency ablation for patients presenting with non-resectable primary or metastatic liver tumours seems to be a valid therapeutic alternative. In the present study, we show a descriptive list of indications, results and complications of Radiofrequency Ablation Technique for treating non-resectable solid hepatic tumours.
MATERIALS AND METHODS: Twenty two patients were included in this study; eleven of them (50%) sustained liver metastases from colorectal adenocarcinoma, ten patients (45.5%) had hepatocellular carcinoma and 1 patient had insulinoma.
RESULTS: Local recurrence rate of hepatocellular carcinoma was 22.7% and 27.3% for colorectal carcinoma, after a respective median follow-up of 21 and 14 months. Complications rate was 6.9% and technique-associated mortality rate was 0%.
CONCLUSIONS: Radiofrequency ablation is an easy to make, safe and useful technique for the treatment of primary and metastatic liver tumours.

Entities:  

Mesh:

Year:  2006        PMID: 17005472     DOI: 10.1007/s12094-006-0040-x

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  25 in total

Review 1.  Radiofrequency ablation of the liver: current status.

Authors:  J P McGhana; G D Dodd
Journal:  AJR Am J Roentgenol       Date:  2001-01       Impact factor: 3.959

Review 2.  Radiofrequency ablation in the treatment of hepatocellular carcinoma--a clinical viewpoint.

Authors:  A Grasso; A F Watkinson; J M Tibballs; A K Burroughs
Journal:  J Hepatol       Date:  2000-10       Impact factor: 25.083

3.  Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma.

Authors:  I de Sio; L Castellano; V De Girolamo; S S di Santolo; A Marone; C Del Vecchio Blanco; G Marone
Journal:  Hepatology       Date:  2001-09       Impact factor: 17.425

4.  Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results.

Authors:  L Buscarini; E Buscarini; M Di Stasi; D Vallisa; P Quaretti; A Rocca
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

5.  Percutaneous hot saline injection therapy for hepatic tumors: an alternative to percutaneous ethanol injection therapy.

Authors:  N Honda; Q Guo; H Uchida; H Ohishi; Y Hiasa
Journal:  Radiology       Date:  1994-01       Impact factor: 11.105

6.  Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.

Authors:  S A Curley; F Izzo; L M Ellis; J Nicolas Vauthey; P Vallone
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

7.  Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.

Authors:  T Livraghi; S N Goldberg; S Lazzaroni; F Meloni; T Ierace; L Solbiati; G S Gazelle
Journal:  Radiology       Date:  2000-03       Impact factor: 11.105

8.  Influencing factors for recurrence of hepatocellular carcinoma treated with radiofrequency ablation.

Authors:  Norio Horiike; Hideto Iuchi; Tuneyuki Ninomiya; Keiko Kawai; Teru Kumagi; Kojiro Michitaka; Toshikazu Masumoto; Morikazu Onji
Journal:  Oncol Rep       Date:  2002 Sep-Oct       Impact factor: 3.906

9.  Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study.

Authors:  Tito Livraghi; Luigi Solbiati; M Franca Meloni; G Scott Gazelle; Elkan F Halpern; S Nahum Goldberg
Journal:  Radiology       Date:  2003-02       Impact factor: 11.105

10.  Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection.

Authors:  T Livraghi; A Giorgio; G Marin; A Salmi; I de Sio; L Bolondi; M Pompili; F Brunello; S Lazzaroni; G Torzilli
Journal:  Radiology       Date:  1995-10       Impact factor: 11.105

View more
  1 in total

Review 1.  Complications of intraoperative radiofrequency ablation of liver metastases.

Authors:  Tsiriniaina Razafindratsira; Milène Isambert; Serge Evrard
Journal:  HPB (Oxford)       Date:  2010-12-07       Impact factor: 3.647

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.